1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3.
Executive Summary
3.1.
Overview of the Market
3.2.
Overview of Key Market Segmentations
3.3.
Overview of Key Market Players
3.4.
Overview of Key Regions/Countries
3.5.
Overview of Market Drivers, Challenges,
Trends
4. Voice of Customer
5.
Global Therapeutic
Vaccines Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Autoimmune Disease Vaccines,
Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccines,
And Other Products)
5.2.2. By Technology (Autologous Vaccines and
Allogeneic Vaccines)
5.2.3. By Type of Therapy (Monotherapy and
Combination Therapy)
5.2.4. By Route of Administration (Intravenous,
Intradermal, Subcutaneous, and Others)
5.2.5. By Distribution Channel (Hospital Pharmacies,
Retail Pharmacies, Online Pharmacies)
5.2.6. By Region
5.2.7. By Company (2022)
5.3. Market Map
6.
North America Therapeutic
Vaccines Market Outlook
6.1.
Market Size &
Forecast
6.1.1. By Value
6.2.
Market Share &
Forecast
6.2.1.
By Product
6.2.2. By Technology
6.2.3. By Type of Therapy
6.2.4. By Route of Administration
6.2.5. By Distribution Channel
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Therapeutic Vaccines
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Technology
6.3.1.2.3.
By Type of Therapy
6.3.1.2.4.
By Route of
Administration
6.3.1.2.5.
By Distribution
Channel
6.3.2. Canada Therapeutic Vaccines
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Technology
6.3.2.2.3.
By Type of Therapy
6.3.2.2.4.
By Route of Administration
6.3.2.2.5.
By Distribution
Channel
6.3.3. Mexico Therapeutic Vaccines
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Technology
6.3.3.2.3.
By Type of Therapy
6.3.3.2.4.
By Route of
Administration
6.3.3.2.5.
By Distribution
Channel
7.
Europe Therapeutic
Vaccines Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Technology
7.2.3. By Type of Therapy
7.2.4. By Route of Administration
7.2.5. By Distribution Channel
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Therapeutic Vaccines
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Technology
7.3.1.2.3.
By Type of Therapy
7.3.1.2.4.
By Route of
Administration
7.3.1.2.5.
By Distribution
Channel
7.3.2. United Kingdom Therapeutic Vaccines
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Technology
7.3.2.2.3.
By Type of Therapy
7.3.2.2.4.
By Route of
Administration
7.3.2.2.5.
By Distribution
Channel
7.3.3. Italy Therapeutic Vaccines Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Technology
7.3.3.2.3.
By Type of Therapy
7.3.3.2.4.
By Route of
Administration
7.3.3.2.5.
By Distribution
Channel
7.3.4. France Therapeutic Vaccines
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Technology
7.3.4.2.3.
By Type of Therapy
7.3.4.2.4.
By Route of Administration
7.3.4.2.5.
By Distribution
Channel
7.3.5. Spain Therapeutic Vaccines Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Technology
7.3.5.2.3.
By Type of Therapy
7.3.5.2.4.
By Route of
Administration
7.3.5.2.5.
By Distribution
Channel
8.
Asia-Pacific Therapeutic
Vaccines Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Technology
8.2.3. By Type of Therapy
8.2.4. By Route of Administration
8.2.5. By Distribution Channel
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Therapeutic Vaccines Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Type of Therapy
8.3.1.2.4.
By Route of
Administration
8.3.1.2.5.
By Distribution
Channel
8.3.2. India Therapeutic Vaccines Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Type of Therapy
8.3.2.2.4.
By Route of
Administration
8.3.2.2.5.
By Distribution
Channel
8.3.3. Japan Therapeutic Vaccines Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Type of Therapy
8.3.3.2.4.
By Route of
Administration
8.3.3.2.5.
By Distribution
Channel
8.3.4. South Korea Therapeutic Vaccines
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Technology
8.3.4.2.3.
By Type of Therapy
8.3.4.2.4.
By Route of Administration
8.3.4.2.5.
By Distribution
Channel
8.3.5. Australia Therapeutic Vaccines
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Technology
8.3.5.2.3.
By Type of Therapy
8.3.5.2.4.
By Route of
Administration
8.3.5.2.5.
By Distribution
Channel
9.
South America Therapeutic
Vaccines Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Technology
9.2.3. By Type of Therapy
9.2.4. By Route of Administration
9.2.5. By Distribution Channel
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Therapeutic Vaccines
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Type of Therapy
9.3.1.2.4.
By Route of
Administration
9.3.1.2.5.
By Distribution
Channel
9.3.2. Argentina Therapeutic Vaccines
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Type of Therapy
9.3.2.2.4.
By Route of
Administration
9.3.2.2.5.
By Distribution
Channel
9.3.3. Colombia Therapeutic Vaccines
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Type of Therapy
9.3.3.2.4.
By Route of
Administration
9.3.3.2.5.
By Distribution
Channel
10.
Middle East and
Africa Therapeutic Vaccines Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Product
10.2.2. By Technology
10.2.3. By Type of Therapy
10.2.4. By Route of Administration
10.2.5. By Distribution Channel
10.2.6. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Therapeutic Vaccines
Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Type of Therapy
10.3.1.2.4.
By Route of Administration
10.3.1.2.5.
By Distribution
Channel
10.3.2. Saudi Arabia Therapeutic Vaccines
Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Type of Therapy
10.3.2.2.4.
By Route of
Administration
10.3.2.2.5.
By Distribution
Channel
10.3.3. UAE Therapeutic Vaccines Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Type of Therapy
10.3.3.2.4.
By Route of
Administration
10.3.3.2.5.
By Distribution
Channel
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Global Oral Clinical Nutrition Market: SWOT Analysis
14.
Porter’s Five Forces Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Products
15. Competitive Landscape
15.1.
Business Overview
15.2.
Service Offerings
15.3.
Recent Developments
15.4.
Key Personnel
15.5.
SWOT Analysis
15.5.1. Agenus Inc.
15.5.2. Argos Therapeutic Inc.
15.5.3. Celldex Therapeutic Inc. (Avant
Immunotherapeutics, Inc.)
15.5.4. Dendreon Corp (Sanpower Group Co.,
Ltd.)
15.5.5. GlaxoSmithKline plc
15.5.6. Merck & Co. Inc.
15.5.7. Novartis AG
15.5.8. Pfizer, Inc.
15.5.9. Phio Pharmaceuticals Corp.
15.5.10.
INOVIO Pharmaceuticals
16.
Strategic Recommendations
17. About Us & Disclaimer